experimental group:oral sirolimus

2 trials

Sponsors

Peking Union Medical College Hospital, Beijing Children’s Hospital, Capital Medical University (National Center for Children’s Health, China)

Conditions

Familial adenomatous polyposisPIK3CA-Related Overgrowth Spectrum (PROS)

Phase 4

Study on the efficacy and safety of rapamycin (sirolimus) in the treatment of familial adenomatous polyposis

RecruitingChiCTR2100046873

Peking Union Medical College HospitalFamilial adenomatous polyposis

Start: 2021-06-30Updated: 2022-01-10

Efficacy and safety of oral sirolimus in the treatment of pediatric PIK3CA-Related Overgrowth Spectrum (PROS)

RecruitingChiCTR2200056185

Beijing Children’s Hospital, Capital Medical University (National Center for Children’s Health, China)PIK3CA-Related Overgrowth Spectrum (PROS)

Start: 2022-07-01Updated: 2024-08-12